Perineural Injections of IncobotulinumtoxinA for Diabetic Neuropathic Pain of the Lower Extremities: Protocol for a Phase 2, Single-Center, Double-Blind, Randomized, Placebo-Controlled Trial (The PINBOT Study)

被引:0
|
作者
Olsen, Marc Klee [1 ]
Thomsen, Trine Hormann [2 ]
Bitcsh, Martin Sabro [2 ]
Enggard, Thomas Peter [3 ]
Simonsen, Louise [2 ]
Jensen, Rigmor Hojland [4 ]
Biering-Sorensen, Bo [1 ]
机构
[1] Rigshosp Glostrup, Neuropath Pain & CRPS Clin, Copenhagen, Denmark
[2] Bispebjerg Hosp, BDept Anaesthesiol, Copenhagen, Denmark
[3] Rigshosp, Multidisciplinary Pain Ctr, Copenhagen, Denmark
[4] Rigshosp Glostrup, Danish Headache Ctr, Copenhagen, Denmark
关键词
Clinical trial; Diabetic neuropathic pain; Perineural injections; IncobotulinumtoxinA; Efficacy; Safety;
D O I
10.1016/j.toxicon.2024.107467
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:66 / 67
页数:2
相关论文
共 50 条
  • [41] A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
    Serpell, M.
    Ratcliffe, S.
    Hovorka, J.
    Schofield, M.
    Taylor, L.
    Lauder, H.
    Ehler, E.
    EUROPEAN JOURNAL OF PAIN, 2014, 18 (07) : 999 - 1012
  • [42] Lacosamide in painful diabetic peripheral neuropathy - A phase 2 double-blind placebo-controlled study
    Rauck, Richard L.
    Shaibani, Aziz
    Biton, Victor
    Simpson, Jqff
    Koch, Brigitte
    CLINICAL JOURNAL OF PAIN, 2007, 23 (02) : 150 - 158
  • [43] Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial
    Goldlust, Samuel A.
    Kavoosi, Mojgan
    Nezzer, Jennifer
    Kavoosi, Mehran
    Korz, Walter
    Deck, Kenneth
    TOXINS, 2021, 13 (04)
  • [44] The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial
    Wang, Hui
    Mu, Wei
    Zhai, Jingbo
    Xing, Dongmei
    Miao, Shujie
    Wang, Jia
    Deng, Yueyi
    Wang, Niansong
    Chen, Hongyu
    Yang, Hongtao
    He, Xuehong
    Shang, Hongcai
    TRIALS, 2013, 14
  • [45] The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial
    Hui Wang
    Wei Mu
    Jingbo Zhai
    Dongmei Xing
    Shujie Miao
    Jia Wang
    Yueyi Deng
    Niansong Wang
    Hongyu Chen
    Hongtao Yang
    Xuehong He
    Hongcai Shang
    Trials, 14
  • [46] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
    Bain, Earle E.
    Robieson, Weining
    Pritchett, Yili
    Garimella, Tushar
    Abi-Saab, Walid
    Apostol, George
    McGough, James J.
    Saltarelli, Mario D.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (03) : 405 - 413
  • [47] Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: A randomized, double-blind, placebo-controlled trial
    Vranken, J. H.
    Hollmann, M. W.
    van der Vegt, M. H.
    Kruis, M. R.
    Heesen, M.
    Vos, K.
    Pijl, A. J.
    Dijkgraaf, M. G. W.
    PAIN, 2011, 152 (02) : 267 - 273
  • [48] Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial
    Mooney, Marc E.
    Herin, David V.
    Specker, Sheila
    Babb, David
    Levin, Frances R.
    Grabowski, John
    DRUG AND ALCOHOL DEPENDENCE, 2015, 153 : 94 - 103
  • [49] Oral IBGard™ Before Colonoscopy: A Single-Center Double-Blinded, Randomized, Placebo-Controlled Trial
    Han, James Y.
    Moosvi, Zain
    Duh, Erica
    Park, Sunhee
    Albers, Gregory C.
    Samarasena, Jason B.
    Karnes, William
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1611 - 1619
  • [50] Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial)
    Morimoto, Satoru
    Takahashi, Shinichi
    Fukushima, Komei
    Saya, Hideyuki
    Suzuki, Norihiro
    Aoki, Masashi
    Okano, Hideyuki
    Nakahara, Jin
    REGENERATIVE THERAPY, 2019, 11 : 143 - 166